EMY explainer looks at recent tirzepatide updates and safety considerations
A general explainer on tirzepatide news and what to keep in mind on safety. Little detail is given beyond the title.
Recap by typeshit. Full story at ΕΜΥ.
A general explainer on tirzepatide news and what to keep in mind on safety. Little detail is given beyond the title.
Recap by typeshit. Full story at ΕΜΥ.
The Times looks at current options for the facial volume loss that can come with rapid GLP-1 weight loss. Full details are on the site.
A Facebook clip has a doctor explaining concerns about muscle loss and hair thinning in people taking GLP-1 medications.
Health NZ is warning that many peptides people inject are unapproved and unregulated, even as demand for the kits keeps growing.
The writer argues the headline merges separate stories, from FDA approval to an 80% visceral fat figure, and says the details don't hold together.
The physician-led longevity service lists GLP-1 management and peptide therapy among its offerings and opens first inside Everhaus Las Vegas in early 2027.
A Harvard and Copenhagen review found 43 percent of users eat too little protein, and a Northwestern study saw deficiencies in nearly one in six teens.
Loading…